drugset / Trial / NCT03953261

Effect of Curcumin on Systemic Lupus Erythematosus

NCT03953261 ↗

Phase 2 Terminated 23 enrolled Loma Linda University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this investigator initiated study is to determine the efficacy of curcumin on disease activity of subjects with systemic lupus erythematous. Curcumin has been found to have anti-inflammatory effects and has been found to improve disease activity in lupus patients. In addition, subjects with rheumatoid arthritis as well as osteoarthritis have also found benefit for their disease activity.

Timeline

Start
2019-09-01
Primary completion
2022-04-13
Completion
2022-04-13

Outcome

Outcome not reported

Stopped: “COVID and lack of support staff 2. lack of support staff to conduct the study”

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 2 g —